ENGLEWOOD, CO / May 17, 2021 / Aytu BioPharma, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, reported financial results for the fiscal third quarter ended March 31, 2021 and provided recent business highlights.The Company also disclosed that in May 2021, Aytu announced the publication of in…
Aytu BioPharma publishes in vitro data demonstrating UV-A light increases mitochondrial anti-viral signaling protein within cells
More from InformationalMore posts in Informational »
- Malaysia Hospital Efforts To Lead Green Revolution Include Use Of UVGI Disinfection Technology
- Far-UVC Light Impacts DNA Of Lung Cells and Tissue
- UV Business News – BIO-UV Alliance With Innovasea Proving Successful
- UV Business News – Atlantic Ultraviolet Launches Disinfection Cabinet With Multiple Industry Applications
- Germicidal UV Tourted As One Solution For Bird Flu Preparedness In Schools